loader
Home/
Annals of Clinical Research and Trials

Full Text


Case Report

Two Cases of Complete Recoveries from Autoimmune and/or Allergic Diseases

Kimihiko Okazaki

Correspondence Address :

Okazaki Medical Clinic
Ukyoku
Kyoto, Japan

Received on: August 24, 2017, Accepted on: August 24, 2017, Published on: August 28, 2017

Citation: Kimihiko Okazaki (2017). Two Cases of Complete Recoveries from Autoimmune and/or Allergic Diseases

Copyright: 2017 Kimihiko Okazaki. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

  • Abstract

  • Fulltext

  • References

  • Tables & Figures

  • Download PDF

Abstract

Fulltext
Text
According to the traditional concept of the contemporary Immunology, neither autoimmune diseases nor allergic diseases can be cured completely. Nevertheless, a fortunate coincidence led me to discovery of a novel concept that eliminations of the causes of these diseases are possible. In other words, combinations of pathogenic antibodies with responsible cells, namely, cytolytic T lymphocytes in cases of autoimmune diseases and mast cells in cases of allergic diseases, can be decomposed by replacing the pathogenic antibodies with non-specific antibodies. In more detail, intradermal injections with a non-specific antigen preparation induce production of non-specific antibodies in the body of the patient. Repetitions of the injections bring about an accumulation of them. Accumulated non-specific antibodies will occupy most of the receptors on the surface of responsible cells. When the  accumulation reaches the sufficient level, virtually no pathogenic antibodies would remain on the receptors. That is, no causes of the diseases remain. Naturally, where there is no cause, there is no disease. Details are demonstrated elsewhere [1].

Case 1
A 52-year-old man (S.Y.) visited my clinic on July 28, 2011. He told me that he had had a morning-stiffness in all of his left hand-finger-joints for five years and that his blood rheumatoid factor measured a couple of weeks earlier had been close to 200U/ mL(normal limit: 15U/mL). I diagnosed him as rheumatoid arthritis and gave him intradermal injections with 0.1ml of 100-fold diluted Neurotropin; a product of Nippon Pharmaceutical Company (Osaka), consisting of an extract of rabbit skin inflamed by inoculation of Vaccinia virus at 1~10 day intervals during the period from July 28, 2011 to December 26, 2014. The total number of the injections was 405.

Case 2
A 56-year-old woman (S.Y.) visited my clinic on September 12, 2011. She told me that her menopause had started at the age of 48 years and that she had had prurigo on her trunk since several months after the start of her menopause. She also told me that her prurigo had expanded to the face lately, which becomes worse with sweat. She claimed of an all-season coryza especially in early mornings. I diagnosed her as allergic rhinitis and dermatitis. I intradermally injected her with 0.1ml of 100-fold diluted Neurotropin at 2~9 day intervals during the period from September 12, 2011 to April 12, 2013. The total number of the injections was 118 at least, of which exact number is unknown. Both of these patients are currently enjoying healthy lives.
References
1. Okazaki K. Therapeutic Significance of Non-Specific Antigens as Anti-Allergic and Anti-Autoimmune Agents. Pharmacometrics. 2009;76:105-107.
Tables & Figures

Download PDF